Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany.
J Ethnopharmacol. 2012 Jun 1;141(2):557-70. doi: 10.1016/j.jep.2011.08.053. Epub 2011 Sep 21.
P-glycoprotein belongs to the family of ATP-binding cassette (ABC) transporters. It functions in cellular detoxification, pumping a wide range of xenobiotic compounds, including anticancer drugs out of the cell. In cancerous cells, P-glycoprotein confers resistance to a broad spectrum of anticancer agents, a phenomenon termed multidrug resistance. An attractive strategy for overcoming multidrug resistance is to block the transport function of P-glycoprotein and thus increase intracellular concentrations of anticancer drugs to lethal levels. Efforts to identify P-glycoprotein inhibitors have led to numerous candidates, none of which have passed clinical trials with cancer patients due to their high toxicity. The search for naturally inhibitory products from traditional Chinese medicine may be more promising because natural products are frequently less toxic than chemically synthesized substances. In this review, we give an overview of molecular and clinical aspects of P-glycoprotein and multidrug resistance in the context of cancer as well as Chinese herbs and phytochemicals showing inhibitory activity towards P-glycoprotein.
P-糖蛋白属于三磷酸腺苷结合盒(ABC)转运蛋白家族。它在细胞解毒中发挥作用,将包括抗癌药物在内的多种外源化合物泵出细胞。在癌细胞中,P-糖蛋白赋予了对广谱抗癌药物的耐药性,这种现象被称为多药耐药性。克服多药耐药性的一种有吸引力的策略是阻断 P-糖蛋白的转运功能,从而将抗癌药物的细胞内浓度增加到致死水平。为了确定 P-糖蛋白抑制剂,已经进行了大量的研究,但是由于其高毒性,没有一种候选药物能够通过癌症患者的临床试验。从中药中寻找天然抑制物可能更有希望,因为天然产物通常比化学合成物质毒性更小。在这篇综述中,我们概述了 P-糖蛋白和多药耐药性在癌症中的分子和临床方面,以及显示出对 P-糖蛋白抑制活性的中草药和植物化学物质。